ロード中...
Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
PURPOSE: Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB refractory to initial SNM and identify patient characteristics associated with these outc...
保存先:
| 出版年: | Int Neurourol J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Continence Society
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790822/ https://ncbi.nlm.nih.gov/pubmed/31607102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1938030.015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|